| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 3e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 1e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0007 |